PROVIDER FILE · Care pathway guides

Livelyhood Review: Following the Care Path for Its Alcohol-Focused GLP-1 Program

Livelyhood markets semaglutide and tirzepatide for people seeking to drink less. Its documents outline a platform-to-clinician-to-pharmacy pathway, but leave important questions about medication details, follow-up and billing.

For someone considering Livelyhood, the central question is not simply which medication appears on its website. It is who evaluates the patient, who decides whether to prescribe, which pharmacy supplies the medication and who responds when something needs attention. Livelyhood presents an alcohol-focused telemedicine service, not primarily a weight-loss clinic. Its homepage markets semaglutide and tirzepatide as “microdose” options, while its privacy policy describes evaluation and treatment of alcohol use disorder.

This review follows those handoffs using four official pages consulted October 19, 2026. The documents distinguish Livelyhood’s technology business from affiliated clinicians and partner pharmacies, and provide useful cancellation and shipment policies. They are less specific about the product a patient receives, response times and the services included in each advertised price. Those gaps matter because an online assessment, a prescription, a shipment and ongoing clinical care are separate steps—not one guaranteed transaction.

At a glance

Clinical responsibility
Livelyhood says it is a technology company, not a medical practice, pharmacy or insurer. Clinical services come from independent healthcare professionals affiliated with OpenLoop Health.
Sources: [4]
Program focus
The platform documents an alcohol-use-disorder focus and markets semaglutide and tirzepatide as “microdose” options. Its homepage identifies alcohol-use-disorder treatment with GLP-1 medicines as off-label.
Sources: [2] [5]
Advertised prices
Monthly plans start at an advertised $199 per month; three-month plans start at an advertised $166 per month. Multiple introductory prices and discounts appear without clear product mapping or a confirmed three-month amount due.
Sources: [5]
Availability
Users must be at least 18 and in the United States during service. The stated 50-state-plus-D.C. reach is qualified by service availability, professional and pharmacy licensing, and state law.
Sources: [4]
Cancellation boundary
Cancellation is available through the account or support email and takes effect at the current billing cycle’s end. Medication cannot be returned or refunded once shipped.
Sources: [3]

Start with the division of responsibility

The terms identify Livelyhood Health, Inc. as the platform operator and include both findlivelyhood.com and the differently spelled findlivelihood.com. More consequentially, they state that Livelyhood is not itself a medical practice, pharmacy or insurer. Clinical services are assigned to independently licensed healthcare professionals affiliated with OpenLoop Health. That distinction tells a prospective patient where prescribing decisions belong, although these pages do not independently verify any individual professional’s credentials.

The pharmacy is a third participant rather than another name for the platform. Livelyhood says prescriptions are fulfilled by partner pharmacies, with assignment depending on the medication, the patient’s state and clinical considerations. A patient therefore needs more than a platform account: the practical care relationship includes a treating clinician and an identifiable dispensing pharmacy. Our guide to clinician and platform responsibilities explains why those roles should remain distinct.

Livelyhood’s documented purpose also deserves attention before enrollment. Its privacy policy describes evaluation and treatment of alcohol use disorder, and the homepage says the program can accompany therapy, 12-step programs and other recovery approaches. That supports reading it as an alcohol-focused service that may coexist with other care. It does not establish that psychotherapy or a structured recovery program is included in the subscription.

Sources: [4] [2] [5]

What happens between signup and a prescribing decision

The advertised entry point is a short assessment, followed by a licensed medical professional’s review of the patient’s history and development of a personalized protocol. The terms add important detail: an evaluation may occur through secure messaging or video when clinically appropriate. They do not promise a particular appointment format for every patient or specify how quickly the assessment will be reviewed. Paying for a consultation does not guarantee a prescription.

The clinician may decline to prescribe, recommend another treatment, request more information or require in-person care. General platform eligibility requires being 18 or older and located in the United States at the time of service. Although the terms advertise all 50 states and Washington, D.C., they also say some services may not be available everywhere. Availability depends on professional licensing, pharmacy licensing and state law; unavailable service should be disclosed during signup without a charge.

The homepage identifies several situations in which someone likely is not a fit: needing high-acuity in-person supervision, being in active crisis or experiencing acute suicidality, having an eating-disorder history, or having a BMI below its prescribing threshold. That threshold is not published in the consulted material. These are the provider’s stated boundaries, not a complete eligibility checklist. Prospective patients should request the actual admission criteria rather than infer them from general GLP-1 prescribing information.

Sources: [4] [5]

Identify the medication before accepting the handoff

The homepage positions semaglutide “microdose” for people who want to drink less without losing weight, and tirzepatide “microdose” for people who want to drink less and lose some weight. These are commercial descriptions, not verified patient outcomes. The consulted pages do not establish the exact route, formulation or presentation offered for either ingredient. The marketing term “microdose” does not resolve those missing product details or provide usable administration instructions.

Livelyhood acknowledges that use for alcohol use disorder is off-label. Its terms also state that compounded medications prescribed through the platform are not FDA approved. Product approval should not be confused with approval of a clinic, pharmacy or alcohol-focused treatment program. FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality; nonapproval alone, however, does not establish clinical inequivalence.

FDA recommends compounded drugs when a patient’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Before proceeding, ask which exact preparation is proposed, why it is being selected and who will explain its instructions. The product and route checklist can help organize that conversation. The refund policy also mentions FDA-approved oral medications, but does not identify them or explain their role in this program.

Sources: [5] [4] [3] [1]

The pharmacy and delivery stages have separate questions

The terms list four pharmacy partners: RedRock Pharmacy in Utah, Health Warehouse in Kentucky, Precision Medicine in New York and Triad Rx in Alabama. Livelyhood describes RedRock, Precision Medicine and Triad Rx as 503A compounding pharmacies licensed in multiple states, and Health Warehouse as a nationally licensed mail-order pharmacy. These are the site’s descriptions, not independent licensing findings. Listing compounding pharmacies does not establish who compounds any particular patient’s preparation.

Livelyhood advertises discreet home delivery without pharmacy visits and says medication arrives quickly. The public documentation does not convert that promise into a review, preparation, dispatch or arrival deadline. Nor does it establish shipping fees, supplies or temperature-control arrangements for a particular product. Ask for the assigned pharmacy’s contact information and expected milestones before shipment. Our pharmacy handoff guide distinguishes questions for the prescriber from questions for the dispenser.

For a missing or damaged shipment, the policy requires contact within seven days of the expected delivery date and says Livelyhood will work with the pharmacy on a no-cost replacement. For the wrong medication or quantity, it instructs patients to stop using it and contact the company for correction and, where appropriate, a refund. Separately, FDA advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or pharmacy.

Sources: [4] [5] [3] [1]

What the advertised prices do—and do not—buy

The homepage supplies real price figures, but their relationship is difficult to reconstruct. Its monthly block starts at $7 per day or $199 per month, while displaying paired prices and a first-month discount. The three-month block uses a similar presentation with a lower advertised monthly starting amount. Neither block clearly assigns each figure to semaglutide or tirzepatide. The table preserves the published figures without treating them as a personalized quote.

A separate promotion offers $99 off total, described as $33 per month off, for choosing three months. Another homepage passage offers a first month for as little as $169. The documentation does not explain whether these offers combine, which one governs checkout or how the three-month total is collected. A three-month plan label alone does not establish mandatory upfront payment, medication quantity or a minimum contractual commitment.

The terms say Stripe processes payments, Livelyhood does not bill insurance and a card statement may show “OPNLP Health.” The initial consultation fee is discussed in the refund policy but not separately priced in the consulted pages. Before paying, obtain a written breakdown of consultation, medication, shipping, supplies, testing and follow-up, plus the next charge’s amount and date. The published documents do not establish that every one of those services is bundled.

Published pricing statements, not confirmed medication-specific quotes
OfferAdvertised figuresUnresolved condition
Monthly starting priceFrom $7/day or $199/monthExact medication and included services
Monthly price block$199, $299/mo; $149, $249; $50 off first monthProduct mapping and applicable introductory charge
Three-month price blockFrom $5.50/day or $166/month; $166, $266/mo; $116, $216; $50 off first monthProduct mapping, amount due and collection schedule
Separate three-month promotion$99 off total, described as $33/mo offWhether it combines with other offers
Separate first-month offerFirst month for as little as $169Eligibility and relationship to the plan blocks
Sources: [5] [4] [3]

Ongoing access needs an operational definition

Livelyhood advertises ongoing provider access and cravings support, and says the provider monitors carefully and remains available for adjustments throughout treatment. Those statements describe a continuing relationship rather than a single prescription transaction. They do not specify scheduled review frequency, response-time standards, support hours or whether cravings support means clinical messaging, structured sessions or another service. Availability outside normal hours and language or interpretation options are also not established in the consulted pages.

The homepage recommends at least six months for what it calls the best results, while advertising plans as short as 30 days. That is the provider’s duration recommendation, not proof of a six-month contractual obligation or a verified outcome. The useful next question is what care occurs during those months: which contacts are scheduled, who initiates them and how concerns reach the prescribing clinician rather than only administrative support.

Follow-up also carries responsibilities for the patient. The refund and cancellation policy permits the clinician to discontinue treatment if it becomes clinically inappropriate, safety concerns arise or the patient does not respond to required follow-up outreach. If discontinuation happens before a scheduled shipment, that shipment will not be charged. Our guide to defining ongoing support offers a framework for clarifying the difference between access, monitoring and required check-ins before enrollment.

Sources: [5] [3]

Cancellation, refunds and the point when shipment matters

Patients can cancel through their account or by emailing support@findlivelyhood.com. The policy places cancellation’s effect at the end of the current billing cycle, rather than promising an immediate financial reversal. It also says cancellation before a scheduled shipment processes prevents that shipment and further charges. Because no processing deadline or renewal-notice schedule is specified, patients should ask how to identify that cutoff and retain confirmation that a request was received.

The initial consultation fee is fully refundable when the provider determines the patient is not a treatment candidate and no medication ships. Once the provider completes an evaluation and issues a prescription, the consultation fee is nonrefundable. Prescription medication cannot be returned or refunded after shipment, including compounded preparations and the unspecified FDA-approved oral medicines mentioned in the policy. These are different boundaries: consultation completion, prescribing and shipping do not mean the same thing.

The policy also excludes prorating or refunding partial billing cycles once a cycle has begun and the associated consultation or medication has been delivered. Approved refunds are typically issued to the original payment method within five to ten business days, depending on the bank; that is not a guaranteed bank-arrival deadline. Separately, the terms contain individual binding arbitration and allow an email opt-out within 30 days of first acceptance, using the subject “Arbitration Opt-Out.”

Sources: [3] [4]

Privacy and records are part of the care pathway

Livelyhood’s privacy policy anticipates collecting medical history, medications, allergies, behavioral-health history, substance-use and treatment history, height, weight and uploaded photographs. For an alcohol-focused service, those disclosures are a substantial part of intake, not simply account registration. Before submitting them, a patient can ask how information moves between the platform, clinician and pharmacy, and how to obtain records if care later transfers elsewhere.

The company says it does not sell personal information and does not use protected health information for marketing to third parties without authorization. Those commitments should be read alongside exceptions for legally required disclosures, valid legal process, protection of rights and safety, adverse-event reporting and disclosures otherwise permitted by HIPAA. Confidentiality therefore is not an absolute promise that information can never be shared.

The policy describes encryption in transit and at rest, access controls, audit logging, workforce training and vendor risk management, while acknowledging that no system is perfectly secure. It also recognizes requests for a medical-record copy and corrections to information believed inaccurate or incomplete. These are useful documented provisions. They do not independently demonstrate how every request is handled, and the consulted material does not provide a specific turnaround time for obtaining records.

Sources: [2]

Questions & answers

Is Livelyhood mainly a weight-loss program?

Not according to the consulted documentation. Its privacy policy describes alcohol-use-disorder evaluation and treatment. The homepage distinguishes semaglutide and tirzepatide partly through advertised weight-related goals, but those promotional descriptions do not establish outcomes. Someone primarily seeking weight-management care should clarify the service’s actual scope before enrolling.

Sources: [2] [5]
Will the consultation be a video appointment?

Possibly, but video is not promised for everyone. The terms allow evaluation through secure messaging or video where clinically appropriate. The clinician can request additional information or in-person care and can decline to prescribe. Ask which format applies to your assessment and whether another appointment could generate a separate charge.

Sources: [4]
Can I choose my dispensing pharmacy?

The terms describe pharmacy assignment based on the medication, state of residence and clinical considerations; they do not establish a patient-choice option. Four partners are listed. Ask which one would receive your prescription, how to reach its pharmacist and whether the quoted price depends on using that assigned pharmacy.

Sources: [4]
What is the confirmed first-month price?

The public presentation does not establish one universal first-month charge. It includes paired discounted figures, a $50 first-month discount and a separate starting-at-$169 statement. Medication mapping and discount compatibility remain unclear. Request the exact checkout charge and subsequent price for the proposed medication rather than relying on the lowest displayed number.

Sources: [5]
Does canceling mean I get my money back?

No. Cancellation and refund eligibility are separate. Cancellation generally takes effect at the current cycle’s end, while shipped medication is nonrefundable and some completed consultations and partial cycles are also excluded. The policy provides a consultation refund when the provider finds the patient unsuitable and no medication ships.

Sources: [3]
What should I do about a missing or damaged order?

Livelyhood asks patients to contact it within seven days of the expected delivery date and says it will arrange a no-cost replacement with the pharmacy. That deadline deserves attention even if tracking remains unresolved. For an injectable GLP-1 arriving warm or insufficiently refrigerated, FDA advises not using it and contacting the provider or pharmacy.

Sources: [3] [1]

Our assessment

Livelyhood documents a recognizable care chain: platform enrollment, independent clinician review, partner-pharmacy dispensing and advertised ongoing support. Its strongest practical disclosures concern professional discretion, qualified geographic availability, shipment problems and refund boundaries. Its weaker points are the exact medication presentation, predictable follow-up arrangements and a coherent medication-specific price. The consulted material does not establish provider-specific treatment outcomes, and promotional claims should not substitute for that evidence. Before enrolling, obtain written confirmation of the treating entity, proposed product, assigned pharmacy, complete charges, follow-up expectations and shipment cutoff for cancellation. Those answers would make the difference between an appealing online offer and an understandable care arrangement.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. Livelyhood — privacy policy ↗
  3. Livelyhood — refund policy ↗
  4. Livelyhood — terms of use ↗
  5. Livelyhood — official website ↗

Continue reading